 For Appointments
617-724-4800
Fax
617-726-9418
Office Address
Massachusetts General Hospital Cancer Center
Gillette Center for Breast Cancer
55 Fruit Street, YAW 9
Boston, MA 02114
Clinical Interests
Breast Cancer and Breast/Ovarian Cancer Genetics
Education
PhD Degree: University of Rochester Medical Center, Rochester, NY, 1990
MD Degree: University of Rochester Medical Center, Rochester, NY, 1994
Postdoctoral Training
Residency: Internal Medicine, Duke University Medical Center, Durham, NC
Fellowship: Medical Oncology, Duke University Medical Center, Durham, NC
Board Certification
Internal Medicine, 1998
Medical Oncology, 2000
My Publications
Link to PubMed Database
Selected Publications
Ryan PD, Goss PE. Adjuvant Hormonal Therapy in Peri- and Postmenopausal Breast Cancer. The Oncologist. 2006;11(7):718-731.
Ryan PD, Harisinghani M, Lerwill M, Kaufman D. Case Records of the Massachusetts General Hospital: Case 6-2006: A 71-year-old woman with urinary incontinence and a mass in the bladder. New England Journal of Medicine. 2006;354:8.
Ryan PD, Goss PE. The Evolving Role of Aromatase Inhibitors in the Treatment of Early-Stage Breast Cancer. In: Natl Clin Pract Oncol. London, UK: Nature Publishing Group 2005;2(12):596-7.
Ryan PD, Kopans DB, Sgroi DC. Case Records of the Massachusetts General Hospital: A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer. New England Journal of Medicine. 2005;353(6):617-22.
Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come S, Schumert ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP. Efficacy of pegfilgrastim and Darbepoetin as Hematopoietic Support for Dose-Dense Every 2 Week Adjuvant Breast Cancer Chemotherapy. J Clin Oncol. 2005;20:23(33):8340-7.
Sgroi DC, Haber DA, Ryan PD, Ma XJ, Erlander MG. RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell. 2004;6(5):445.
Ma X-J, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG and Sgroi DC. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5:607-16.
| 
